Global Presence United Imaging Intelligence has established a significant international footprint with offices in Shanghai and Boston, providing opportunities to collaborate with hospitals, research institutions, and healthcare providers across North America and Asia for AI-driven medical solutions.

Diverse Product Portfolio The company offers over 10 AI platforms and more than 100 applications, with a strong focus on AI for radiology, oncology, and biomedical research, enabling tailored solutions for hospitals seeking advanced diagnostic and treatment tools.

Regulatory Approvals With 15 FDA-cleared products, 31 CE-marked solutions, and 15 Class III NMPA certifications, UII demonstrates robust regulatory compliance, facilitating market entry in the US, Europe, and China—ideal points for expanding sales channels.

Recent Innovation Launches UII has recently introduced cutting-edge tools like Yuanzhi, uAI MERITS, and uAI SAT, showcasing their commitment to technological advancement and presenting new opportunities for sales of AI-powered imaging, annotation, and metaverse-based surgical systems.

Market Focus UII's active participation in industry events like RSNA 2025 and collaborations with physicians on disease-specific AI models indicate a strong focus on high-impact medical areas such as oncology and stroke management, opening avenues for targeted product pitches and strategic partnerships.